Harrisvaccines was awarded Iowa Life Sciences Company of the year by the Technology Association of Iowa at its seventh annual Prometheus Awards gala held in Des Moines.

The Prometheus Awards is Iowa's largest, most prestigious distinction recognizing and celebrating innovation in Iowa's high-tech industry. The ceremony honors both companies and individuals who have demonstrated outstanding leadership and excellence in technology.

“We are thrilled to be named Iowa Life Sciences Company of the Year,” says D.L. “Hank” Harris, Ph.D., D.V.M., president and founder of Harrisvaccines. “It is public recognition of Harrisvaccines’ exceptionally talented staff and the innovative platform we employ.”

An Iowa State University start-up company formed six years ago, Harrisvaccines primarily focuses on developing vaccines for diseases effecting animals including the economically devastating swine influenza virus (SIV) and porcine respiratory and reproductive syndrome virus (PRRSV) in pigs; and white spot syndrome virus (WSSV) and infectious myonecrosis virus (IMNV) in farmed shrimp.

The company has also been recently chosen to provide expertise in RNA manufacturing for a U.S. Department of Defense contract to develop and produce a vaccine against the deadly Ebola and Marburg viruses, considered to be potential biological terrorism agents.